The press typically treats lawsuits against business as inherently righteous and amplifies the junk science behind them. So in case you missed it, a federal judge on Tuesday dismissed claims that ...

US health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk t… ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

People who are taking over-the-counter ranitidine should consider taking one of several other heartburn drugs that are available.

Popular heartburn drug Ranitidine, long under scrutiny, will continue to be available in India as the government confirmed it had no plans to ban its manufacture or sale. The government had ...

Lab investigates heartburn drug’s possible cancer link Washington — U.S. health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after ...

Topline Pharmaceutical heavyweight GSK on Wednesday said it had settled four lawsuits in the U.S. that claimed its popular heartburn drug Zantac causes cancer, averting a trial due to start in ...

Zantac is a drug that companies have pulled from the market due to concerns about its cancer risk. Learn more about the risks here.

There are multiple drugs on the market that are approved for the same or similar uses as ranitidine. Still, if you’re a daily user of such medications, it’s probably worth thinking about.

Novartis halts distribution of Zantac heartburn medication due to contaminant Medication already in stores will still be available as FDA reviews safety of ingredient linked to increase in cancer ...

Ranitidine is certainly not the only medication available for heartburn, stomach ulcers, and other stomach acid-related problems.